Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	8 Months Ended	9 Months Ended	1 Months Ended
	Oct. 01, 2011 Successor	Sep. 29, 2012 Successor	Jan. 28, 2011 Predecessor
Operating activities
Net loss	$ (54,691)	$ (11,005)	$ (18,120)
Adjustments for non-cash transactions:
Deferred income taxes	945	103	0
Depreciation and amortization expense	41,008	49,466	3,535
Inventory step-up related to merger	13,012	0	0
Inventory absorption related to step-up depreciation	(181)	0	0
(Gain) loss on derivatives and other financial instruments	0	(147)	187
(Gains) losses on sale of assets, net	703	(8)	(25)
Non-cash compensation	687	620	13,591
Changes in operating assets and liabilities:
Accounts receivable, net	(22,004)	9,079	(3,287)
Inventories, net	(5,427)	5,010	(2,988)
Other current assets	32,862	(3,584)	(38,025)
Accounts payable and accrued liabilities	(7,670)	4,577	17,238
Other, net	792	1,519	2,624
Net cash provided by (used in) operating activities	36	55,630	(25,270)
Investing activities
Purchases of property, plant and equipment	(53,756)	(40,146)	(8,405)
Proceeds from sale of assets	11,010	1,657	105
Acquisition of noncontrolling interest	(7,246)	0	0
Acquisition of intangibles and other	(168)	(175)	(5)
Acquisition of Polymer Group, Inc.	(403,496)	0	0
Net cash used in investing activities	(453,656)	(38,664)	(8,305)
Financing activities
Proceeds from Issuance of Senior Secured Notes	560,000	0	0
Proceeds from long-term borrowings	10,281	10,977	31,500
Proceeds from short-term borrowings	5,245	4,943	631
Repayment of Term Loan	(286,470)	0	0
Repayment of long-term borrowings	(50,133)	(3,249)	(24)
Repayment of short-term borrowings	(34,874)	(6,894)	(665)
Loan acquisition costs	(19,252)	0	0
Issuance of common stock	259,865	0	0
Net cash provided by financing activities	444,662	5,777	31,442
Effect of exchange rate changes on cash	558	(386)	549
Net increase (decrease) in cash and cash equivalents	(8,400)	22,357	(1,584)
Cash and cash equivalents at beginning of period		72,742	72,355
Cash and cash equivalents at end of period	$ 62,371	$ 95,099	$ 70,771